Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia

Fig. 3

CD9+ cells promote leukemia growth. a Bioluminescent images showed that the total flux of the leukemia derived from CD9+ THP-1 cells (left) and CD9− THP-1 cells (right) after tail vein injected in NOG mice. Signal intensity is represented as p/s/cm2/sr. b Quantification showed that the total flux of the leukemia derived from CD9+ THP-1 cells and CD9− THP-1 cells after tail vein injected in NOG mice (n = 6). c The proportion of CD9+ cells in mice bone marrow. Error bars show the ±SD. d The proportion of CD9+ cells in mice peripheral blood. Error bars show the ±SD

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512